R&G PharmaStudies Co., Ltd. approved the cash dividend of CNY 2.50 (tax included) per 10 shares for the year 2022, at the AGM held on May 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.2 CNY | -0.05% | -2.51% | -33.00% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.00% | 573M | |
+22.65% | 87.14B | |
-23.68% | 75.59B | |
+1.76% | 26.78B | |
+3.99% | 17.89B | |
-13.47% | 16.44B | |
+2.68% | 15.68B | |
+69.13% | 13.3B | |
+74.99% | 13.06B | |
+3.11% | 12.54B |
- Stock Market
- Equities
- 301333 Stock
- News R&G PharmaStudies Co., Ltd.
- R&G Pharmastudies Co., Ltd. Approves the Cash Dividend for the Year 2022